Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

计划入组 32 人 · 首次发布于 2024 年 7 月 9 日

Long-term Follow-up Gene Therapy Study for RPGR- XLRP

计划入组 42 人 · 首次发布于 2020 年 3 月 18 日

Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa

计划入组 18 人 · 首次发布于 2023 年 5 月 24 日

RPGR gene therapy (Neurophth)

AAV-RPGR gene therapy (University of Florida/University of Pennsylvania)

Cotoretigene toliparvovec

CELL AND GENE THERAPY CATAPULT

United Kingdom

JIUYUAN GENE

Triple-Gene LLC

United States

Phase 2 SKYLINE Trial Shows Promising Results for Gene Therapy in X-Linked Retinitis Pigmentosa

Beacon Therapeutics' Laru-zova Shows Promise in Phase 2 Trial for XLRP

FDA Grants RMAT Designation to Gene Therapies for Retinitis Pigmentosa